Microtubule Inhibitor
5 drugs across 2 manufacturers|5 Generic,0 Brand
The Microtubule Inhibitor class contains 5 NDCs from 2 manufacturers (5 generic, 0 brand), at an average NADAC of $1.89 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
5
5G / 0B
Manufacturers
2
Avg $1.8895/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 5 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PACLITAXEL 30 MG/5 ML VIAL PACLITAXEL | $2.1290 per ML | — |
PACLITAXEL 100 MG/16.7 ML VIAL PACLITAXEL | $1.8891 per ML | — |
PACLITAXEL 100 MG/16.7 ML VIAL Paclitaxel | $1.8891 per ML | — |
PACLITAXEL 300 MG/50 ML VIAL PACLITAXEL | $1.7700 per ML | — |
PACLITAXEL 300 MG/50 ML VIAL Paclitaxel | $1.7700 per ML | — |
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Hospira Inc. manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
PACLITAXEL market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Microtubule Inhibitor class?
The Microtubule Inhibitor class contains 5 NDCs from 2 manufacturers — 5 generic and 0 brand products.
What is the average price of Microtubule Inhibitor drugs?
The average NADAC for the Microtubule Inhibitor class is $1.8895 per unit across 5 NDCs.
Which manufacturers make Microtubule Inhibitor drugs?
2 manufacturers make drugs in the Microtubule Inhibitor class. Ranked by number of NDCs, the largest are Hospira Inc. (3), Fresenius Kabi USA, LLC (2).